NIPPON INDIA PHARMA FUND
Nippon India Mutual Fund
Sectoral / Thematic Highly Differentiated As of 2026-05-31
Holdings
34
Concentrated
Top 10 weight
59%
Concentration
Active share
90%
Highly Differentiated
Equity
-
Asset allocation
Portfolio
3Sectors
19High-conviction bets
72%Top sector wt.
-Cash
Market-cap allocation
Large cap40%
Mid cap27%
Small cap30%
Asset allocation
Asset mix not available.
Top holdings
13.4%
Lupin LimitedEQUITY
7.3%6.7%
Cipla LimitedEQUITY
6.2%5.8%
5.2%
Mankind Pharma LimitedEQUITY
3.9%3.7%
3.4%
3.2%
Ajanta Pharma LimitedEQUITY
3.2%3.0%
2.6%
2.4%
2.3%
Aurobindo Pharma LimitedEQUITY
2.3%Abbott India LimitedEQUITY
2.3%Triparty RepoCASH_EQUIVALENT
2.2%Gland Pharma LimitedEQUITY
2.1%2.1%
1.9%
1.8%
1.8%
Pfizer LimitedEQUITY
1.7%1.5%
1.3%
1.2%
1.1%
0.9%
0.9%
Sanofi India LimitedEQUITY
0.8%Biocon LimitedEQUITY
0.7%0.6%
Indoco Remedies LimitedEQUITY
0.5%Concord Biotech LimitedEQUITY
0.1%Net Current AssetsCASH_EQUIVALENT
-0.1%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- Concentrated in Pharmaceuticals & Biotechnology - watch sector risk.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund290 holdings · 36% AS
Franklin India Multi-Factor Fund93 holdings · 84% AS
Bandhan Business Cycle Fund93 holdings · 65% AS
WhiteOak Capital Special Opportunities Fund90 holdings · 73% AS
UTI Quant Fund89 holdings · 66% AS
Axis India Manufacturing Fund86 holdings · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
72.4%
21.9%
3.7%